CLASS II Drug recall · Reported 25 Nov 2020 · FDA Enforcement Report

Sodium Chloride Injection recalled by Hikma Pharmaceuticals USA

Hikma Pharmaceuticals USA is recalling Sodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/mL Single Dose Vial, Preservative Free, distributed nationwide in the US. The recall was initiated on 3 Nov 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesa) Vial Lot #s: 078338 Exp. 7/2021; Lot 088391, Exp. 08/2021; 098340, Exp. 09/2021; 108325 Exp. 10/2021; 010018 Exp. 1/2023; b) Carton Lot #: 068322, Exp. 06/2021.
NDC0641-0497, 0641-6144
Quantity recalled2,100,646 Vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0101-2021
FDA event ID
86685
Recalling firm
Hikma Pharmaceuticals USA, Cherry Hill, NJ
Manufacturer
Hikma Pharmaceuticals USA Inc.
Classification
Class II
Status
Terminated
Recall initiated
3 Nov 2020
FDA classified
20 Nov 2020
Reported
25 Nov 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

3 Nov 2020Recall initiated by company
20 Nov 2020Classified by FDA+17 days
25 Nov 2020Published in enforcement report+5 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed pH Specifications: Out of Specification pH Test Results were found in Sodium Chloride Injection USP 0.9% 2 mL vial.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Sodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/mL, 2mL Single Dose Vial, Preservative Free, For use as a sterile diluent, Rx Only, Mfd. by. West-ward Eatontown, NJ 07724 USA, a) Vial NDC 0641-0497-17, b) Carton of 25 vials NDC 0641-0497-25.

Where it was distributed

Nationwide in the U.S.

Nationwide

Questions about this recall

Why was it recalled?

Failed pH Specifications: Out of Specification pH Test Results were found in Sodium Chloride Injection USP 0.9% 2 mL vial.

Which lots are affected?

a) Vial Lot #s: 078338 Exp. 7/2021; Lot 088391, Exp. 08/2021; 098340, Exp. 09/2021; 108325 Exp. 10/2021; 010018 Exp. 1/2023; b) Carton Lot #: 068322, Exp. 06/2021.

Where was it sold?

Nationwide in the U.S.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Hikma Pharmaceuticals USA

All 20

Other Sodium Chloride recalls

All 132